Nevro Corp. (NVRO) earnings
NVRO earnings moved a median of -2.69% by the close. Quarterly and annual NVRO reports and results, each read against the price at its own news timestamp. Back to the NVRO overview →
13 measured NVRO earnings events.
Where these NVRO earnings landedvs 13 measured NVRO earnings reactions
| Middle 50% of NVRO earnings reactions | -12.11% to +0.87% |
|---|---|
| Median reaction (to close) | -2.69% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 NVRO earnings events with a measured close landed between -12.11% and +0.87%; 31% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K NEVRO CORP For: Dec 31 | SEC filing · Form 10-K | +0.35% | +0.87% | |
| Form 10-Q NEVRO CORP For: Sep 30 | SEC filing · Form 10-Q | -3.50% | -24.70% | |
| Nevro Reports Third-Quarter 2024 Financial Results | Press release | -3.50% | -24.70% | |
| Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 | Press release | +0.00% | +4.77% | |
| Form 10-Q NEVRO CORP For: Jun 30 | SEC filing · Form 10-Q | -4.20% | -7.82% | |
| Nevro Reports Second-Quarter 2024 Financial Results | Press release | -4.20% | -7.82% | |
| Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 | Press release | -1.83% | +4.71% | |
| Form 10-Q NEVRO CORP For: Mar 31 | SEC filing · Form 10-Q | -1.86% | -12.11% | |
| Nevro Reports First-Quarter 2024 Financial Results | Press release | -1.86% | -12.11% | |
| Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024 | Press release | +0.00% | -2.69% | |
| Form 10-K NEVRO CORP For: Dec 31 | SEC filing · Form 10-K | +1.42% | +3.51% | |
| Form 10-Q NEVRO CORP For: Sep 30 | SEC filing · Form 10-Q | +1.87% | +0.00% | |
| Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance | Press release | +1.87% | +0.00% |
Keep exploring
More NVRO: analyst actions → · SEC filings → · NVRO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Avalon GloboCare Corp. (AVCO) | 254 | 0.00% | 41% |
| Editas Medicine, Inc. (EDIT) | 253 | -1.15% | 39% |
| DarioHealth Corp. (DRIO) | 252 | 0.00% | 45% |
| Cue Biopharma, Inc. (CUE) | 251 | -0.05% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.